.

.

28424

Nasalgen 3-PMH 50ds

Merck - Bovilis Nasalgen 3-PMH Intranasal BRD vaccine for cattle provides protection against the most common viral and bacterial pneumonia-causing pathogens in one dose.

$168.85
Quantity

Merck Bovilis Nasalgen 3-PMH Intranasal BRD vaccine for cattle provides protection against the most common viral and bacterial pneumonia-causing pathogens in one dose. Effectively protects beef and dairy cattle and calves against bovine respiratory syncytial virus (BRSV), infectious bovine rhinotracheitis (IBR), parainfluenza (PI3), Pasteurella multocida, and Mannheimia haemolytica. Can be given to calves as young as 7 days, along with pregnant cows and calves nursing pregnant cows. Does not interfere with maternal antibodies from colostrum. Nasalgen 3-PMH vaccine imitates natural exposure to these major causes of respiratory disease, providing an enduring immune system response to subsequent disease challenges. The 2-ml vaccine is delivered directly to the mucosal (intranasal) surfaces, stimulating a strong, early immune response. Provides six-and-one-half months’ duration of immunity against IBR; four months against P. multocida and M. haemolytica; eleven-weeks against BRSV and three-months against PI3. Unique blue shadow dye to confirm vaccine has been administered. Intranasal administration meets best management practices through the Beef Quality Assurance program.

Species: Beef and dairy cattle and calves

FEATURES / BENEFITS

The first intranasal BRD vaccine against viral and bacterial pneumonia.

Unique blue shadow dye clearly indicates which animals have been vaccinated; prevents double dosing or missing a dose.

Proven safe for use in pregnant cows and in calves nursing pregnant cows, as well as young calves.

Develops serum and mucosal antibody response within 2 weeks of vaccination.

Stimulates strong, lasting protection against IBR, BRSV, PI3, P. multocida and M. haemolytica.

SPECIFICATIONS

Safe for use in pregnant cows or in calves nursing pregnant cows.

Meat withhold 21 days.

For intranasal use.

Store refrigerated at 2 to 7 ˚C (35 to 45 ˚F). Do not freeze.

Use immediately after reconstituting product. Discard any unused portions.

USDA approved.

10 and 25 dose packing includes a transfer needle. Use caution upon opening.

Anaphylactoid reactions may occur following use; administer Epinephrine.

Contains penicillin and streptomycin as a preservative; in case of human exposure, contact a physician.

INSTRUCTIONS

Rehydrate freeze-dried vial with part of the accompanying vial of diluent using the provided transfer needle.

Mix reconstituted vial well and transfer rehydrated vaccine into diluent vial using transfer needle.

Remove transfer needle from the former diluent vial and mix reconstituted vial well.

Peel label from the vaccine vial and place on diluent vial containing all vaccine.

Shake product well and administer a 2-ml dose by the intranasal route.

For advice on revaccination frequency, contact your veterinarian.

Merck
28424

Specific References

related products